Tao Ouyang

4PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 07, 2025
A Non-Inferior Randomized Trial of Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Premenopausal Patients With Hormone-Responsive and HER2-Negative Lymph Node-Negative Breast Cancer.

Chongshan Gu, Yingjian He, Nan Zhang

|Aug 02, 2022
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study.

Xinguang Wang, Zhaoqing Fan, Xing Wang

|Jun 12, 2021
Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab.

Lize Wang, Yang Zhang, Yingjian He

|Jun 11, 2020
Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy.

L Wang, Y Li, J Li

Pageof 1

Frequent Collaborators

1 joint publications

Lize Wang

1 joint publications

Zhaoqing Fan

1 joint publications

Chongshan Gu